RRM2 and hereditary clear cell renal cell carcinoma: Recent studies have demonstrated that the dysregulation of RRM2 is associated with certain types of malignancy, including renal cell carcinoma [11], lung cancer [12,13], glioblastoma [14], and breast cancer [15].